These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29730476)

  • 1. AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.
    Philippe C; Pinson B; Dompierre J; Pantesco V; Viollet B; Daignan-Fornier B; Moenner M
    Neoplasia; 2018 Jun; 20(6):555-562. PubMed ID: 29730476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
    Agarwal S; Bell CM; Rothbart SB; Moran RG
    J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
    Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
    J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells.
    Santidrián AF; González-Gironès DM; Iglesias-Serret D; Coll-Mulet L; Cosialls AM; de Frias M; Campàs C; González-Barca E; Alonso E; Labi V; Viollet B; Benito A; Pons G; Villunger A; Gil J
    Blood; 2010 Oct; 116(16):3023-32. PubMed ID: 20664053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses.
    Rao E; Zhang Y; Li Q; Hao J; Egilmez NK; Suttles J; Li B
    Oncotarget; 2016 Jun; 7(23):33783-95. PubMed ID: 27177226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
    Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
    J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts.
    González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J
    Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner.
    Sun Y; Connors KE; Yang DQ
    Mol Cell Biochem; 2007 Dec; 306(1-2):239-45. PubMed ID: 17786544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellation.
    Favero CB; Mandell JW
    Brain Res; 2007 Sep; 1168():1-10. PubMed ID: 17706943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aminoimidazole-4-carboxyamide-1-β-D-ribofranoside stimulates the rat enhancer of split- and hairy-related protein-2 gene via atypical protein kinase C lambda.
    Komatsu Y; Yanagisawa Y; Moriizumi M; Tsuchiya Y; Yokouchi H; Otsuka H; Aoyagi M; Tsukada A; Kanai Y; Haneishi A; Takagi K; Asano K; Ono M; Tanaka T; Tomita K; Yamada K
    J Biochem; 2016 Apr; 159(4):429-36. PubMed ID: 26590300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
    Zajkowicz A; Rusin M
    Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts.
    Hattori Y; Akimoto K; Nishikimi T; Matsuoka H; Kasai K
    Hypertension; 2006 Feb; 47(2):265-70. PubMed ID: 16380538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-b-D-ribonucleoside, regulates lactate production in rat Sertoli cells.
    Galardo MN; Riera MF; Pellizzari EH; Cigorraga SB; Meroni SB
    J Mol Endocrinol; 2007 Oct; 39(4):279-88. PubMed ID: 17909267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
    Goirand F; Solar M; Athea Y; Viollet B; Mateo P; Fortin D; Leclerc J; Hoerter J; Ventura-Clapier R; Garnier A
    J Physiol; 2007 Jun; 581(Pt 3):1163-71. PubMed ID: 17446219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway.
    Hsu MH; Savas U; Lasker JM; Johnson EF
    J Pharmacol Exp Ther; 2011 Apr; 337(1):125-36. PubMed ID: 21205922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.